 |
|
High levels of lipoprotein(a) in women associated with increased risk for cardiovascular events
September 20, 2006Women with extremely high levels of lipoprotein(a), particularly those with high levels of low-density lipoprotein cholesterol, have an increased risk for cardiovascular events, according to a study in the September 20 issue of JAMA.
Lipoprotein(a) is a specific class of lipoprotein particles found in human plasma, and differs from low-density lipoprotein cholesterol (LDL-C), according to background information in the article. Studies of lipoprotein(a) have shown contrasting results, leading to disagreement about the clinical utility of routinely measuring lipoprotein(a). There is also poor agreement among lipoprotein(a) levels obtained by different tests.
Jacqueline Suk Danik, M.D., M.P.H., of Brigham and Women's Hospital, Boston, and colleagues conducted a study to determine the association of lipoprotein(a) levels with the incidence of future cardiovascular events, such as nonfatal heart attack, nonfatal stroke, coronary revascularization procedures, and cardiovascular-related death. The study included 27,791 initially healthy women in the Women's Health Study, enrolled between November 1992 and July 1995 and followed up for 10 years. Lipoprotein(a) level was measured in blood samples obtained at baseline.
During follow-up, there were 899 new cardiovascular events. In analyses controlling for age, smoking, blood pressure, body mass index, total cholesterol, high-density lipoprotein cholesterol, diabetes, hormone use, C-reactive protein (CRP), and randomization treatment groups, women in the highest quintile of lipoprotein(a) were 1.47 times more likely to develop cardiovascular events than women in the lowest quintile.
"In this large prospective cohort study of initially healthy women, extremely high levels of lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform [a type of protein] size, were associated with increased cardiovascular disease risk, particularly in women with high LDL-C levels. This relationship existed independently of traditional risk markers, and CRP. However, these results were driven almost exclusively by extremely elevated lipoprotein(a) levels among those with above median LDL-C levels, with almost no risk gradient in individuals with lower lipoprotein(a) levels, which constituted the majority of individuals screened," the authors write.
"While [our results are] of pathophysiological interest, we do not believe our data support generalized screening of lipoprotein(a) in the population as a whole because only extremely high levels were associated with cardiovascular risk. Determination of lipoprotein(a) levels should thus be reserved for high-risk subsets of the population such as individuals with premature [heart attack] who have otherwise normal risk profiles or are at particularly high risk because of circumstances such as familial hypercholesteremia," the researchers write.
JAMA and Archives Journals
During follow-up, there were 899 new cardiovascular events. In analyses controlling for age, smoking, blood pressure, body mass index, total cholesterol, high-density lipoprotein cholesterol, diabetes, hormone use, C-reactive protein (CRP), and randomization treatment groups, women in the highest quintile of lipoprotein(a) were 1.47 times more likely to develop cardiovascular events than women in the lowest quintile.
"In this large prospective cohort study of initially healthy women, extremely high levels of lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform [a type of protein] size, were associated with increased cardiovascular disease risk, particularly in women with high LDL-C levels. This relationship existed independently of traditional risk markers, and CRP. However, these results were driven almost exclusively by extremely elevated lipoprotein(a) levels among those with above median LDL-C levels, with almost no risk gradient in individuals with lower lipoprotein(a) levels, which constituted the majority of individuals screened," the authors write.
"While [our results are] of pathophysiological interest, we do not believe our data support generalized screening of lipoprotein(a) in the population as a whole because only extremely high levels were associated with cardiovascular risk. Determination of lipoprotein(a) levels should thus be reserved for high-risk subsets of the population such as individuals with premature [heart attack] who have otherwise normal risk profiles or are at particularly high risk because of circumstances such as familial hypercholesteremia," the researchers write.
JAMA and Archives Journals
Lipoprotein Current Events and Lipoprotein News RSSGenetic analysis helps dissect molecular basis of cardiovascular disease
Using highly precise measurements of plasma lipoprotein concentrations determined by nuclear magnetic resonance spectroscopy (NMR), researchers led by Daniel Chasman at Brigham and Women's Hospital and Harvard Medical School in Boston, MA, the Framingham Heart Study in Framingham, and the PROCARDIS consortium in Stockholm, Sweden and Oxford, England performed genetic association analysis across the whole genome among 17,296 women of European ancestry from the Women's Genome Health Study.
Adding ezetimibe to atorvastatin improves lipid control
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone.
Metabolic syndrome linked to liver disease in obese teenaged boys
Researchers studying a large sample of adolescent American boys have found an association between metabolic syndrome, which is a complication of obesity, and elevated liver enzymes that mark potentially serious liver disease.
Lead in bone associated with increased risk of death from cardiovascular disease in men
Growing evidence shows that exposure to lead in the environment is associated with cardiovascular disease, including increased risk of hypertension.
UCLA scientists uncover immune system's role in bone loss
Got high cholesterol? You might want to consider a bone density test. A new UCLA study sheds light on the link between high cholesterol and osteoporosis and identifies a new way that the body's immune cells play a role in bone loss.
More patients across the world lowering 'bad' cholesterol
The percentage of patients lowering their elevated "bad" cholesterol to within target levels nearly doubled in the last decade, according to a multi-national survey reported in Circulation: Journal of the American Heart Association.
Exercise improves functional and psycological ability and reduces steroid need in rheumatoid arthritis
Undertaking a supervised exercise programme can have beneficial effects on functional status and physical function, reduce the need for daily corticosteroid and anti-inflammatory intake and improve levels of depression and anxiety in people with rheumatoid arthritis (RA).
Hormone therapy plus physical activity reduce belly fat, body fat percentage after menopause
Older women who take hormone therapy to relieve menopausal symptoms may get the added benefit of reduced body fat if they are physically active, according to a new study.
UT Southwestern researchers pinpoint where 'bad' cholesterol levels are controlled
Researchers at UT Southwestern Medical Center have found that a protein responsible for regulating "bad" cholesterol in the blood works almost exclusively outside cells, providing clues for the development of therapies to block the protein's disruptive actions.
New research suggests common anti-seizure medications may increase risk of cardiovascular problems
An important clinical repercussion in the treatment of epilepsy has been discovered by a research team led by Scott Mintzer, M.D., assistant professor in the Department of Neurology and the Jefferson Comprehensive Epilepsy Center at Jefferson Medical College of Thomas Jefferson University.
More Lipoprotein Current Events and Lipoprotein News Articles
 |
Biochemistry of Lipids, Lipoproteins and Membranes, Fifth Edition (New Comprehensive Biochemistry) by J.E. Vance (Editor), Dennis E. Vance (Editor) Research on the biochemistry and molecular biology of lipids and lipoproteins has experienced remarkable growth in the last 20 years, particularly with the realization that many different classes of lipids play fundamental roles in diseases such as heart disease, obesity, diabetes, cancer and neurodegenerative disorders. The 5th edition of this book has been written with two major objectives. The first objective is to provide students and teachers with an advanced up-to-date textbook covering the major areas of current interest in the lipid field. The chapters are written for students and researchers familiar with the general concepts of lipid metabolism but who wish to expand their knowledge in this area. The second objective is to provide a reference text for scientists who are about... |
 |
Source Naturals Policosanol Cholesterol Complex, Tablets, 90 tablets by Source Naturals Dietary supplement. Bio Align. Policosanol Cholesterol Complex, part of the Cholesterol Rescue family of products, is a Bio-Aligned formula that supports cholesterol wellness by helping to maintain multiple interdependent body organs and systems; heart, blood vessels, nervous system, thyroid, liver and gastrointestinal tract. (These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.) |
 |
High-Density Lipoproteins (HDL) Form a Class of Lipoproteins Photographic Poster Print, 24x24 by AllPosters.com AllPosters.com is the world's #1 seller of posters, prints, photographs, specialty products and framed art. We're dedicated to bringing our customers the best selection of high quality wall décor that is perfect for their home or office. Browse our catalog of over 300,000 items that include entertainment and specialty posters, decorative prints, and art reproductions. Whether you're looking for your favorite movie or music poster, a framed Monet reproduction, or a print of the Eiffel Tower you will find it at AllPosters.com. Visit our Amazon store today at www.amazon.com/allposters to find Special Offers and search by subject category or artist. AllPosters.com provides unmatched service with a 100% satisfaction guarantee. We ship internationally to over 80 countries. Decorate your... |
 |
Lipoprotein Protocols (Methods in Molecular Biology) by Jose M. Ordovas (Editor) Tufts Univ., Boston, MA. Presents a set of molecular biology and protein techniques designed for use in the laboratory. Focuses on the practical aspects of the methods, including solving problems. Halftone illustrations. Outline format. |
 |
Cholesterol: Raising the Good and Lowering the Bad (Home Use) By now, most people have heard the term HDL - good cholesterol, and LDL - bad cholesterol. But do you know what makes good cholesterol good and bad cholesterol bad? And how does the wrong combination of these lipoproteins affect the risk of heart disease? This program will delve into these important questions and provide you with the answers you need to control your cholesterol. This product is manufactured on demand using DVD-R recordable media. Amazon.com's standard return policy will apply. |
 |
Polymedco Calibrator Lipoprotein 1ml 5/pk - Model Lpac400 by Polymedco, Inc Polymedco Calibrator Lipoprotein 1ml 5/Pk - Model LPAC400 : This product is being shipped directly to you from the manufacturer, and as such, may incur seperate delivery fees, plus freight charges. Please allow 4-6 weeks for delivery. SPECIAL NOTE: All special ordered items are "NON-RETURNABLE" This product is a refrigerated product and will be shipped separately. Refrigerated items do not ship on Friday unless prior arrangements are made for Saturday delivery. |
 |
High Cholesterol Paper Paper Unmounted by Anatomical Chart Company |
 |
Handbook of Lipoprotein Testing, 2nd Edition by Nader Rifai (Author), G. Russell Warnick (Author), Marek H. Dominiczak (Author), Nader Rifai (Editor), G. Russell Warnick (Editor), Marek H. Dominiczak (Editor) This important reference addresses critical issues in lipoprotein testing such as standardization, certification, and measurement and interpretation of lipid values, and comprehensively presents the latest advances in lipid testing. It also includes methodologies such as the determination of plasma lipoprotein lipase activity and low-density lipoprotein receptors. It will be of great interest to clinical pathologists, lipid chemists, and all laboratorians involved in lipidology and cardiovascular prevention. |
|
|
High-Density Lipoproteins (HDL) Form a Class of Lipoproteins Photographic Poster Print, 16x16 by AllPosters.com AllPosters.com is the world's #1 seller of posters, prints, photographs, specialty products and framed art. We're dedicated to bringing our customers the best selection of high quality wall décor that is perfect for their home or office. Browse our catalog of over 300,000 items that include entertainment and specialty posters, decorative prints, and art reproductions. Whether you're looking for your favorite movie or music poster, a framed Monet reproduction, or a print of the Eiffel Tower you will find it at AllPosters.com. Visit our Amazon store today at www.amazon.com/allposters to find Special Offers and search by subject category or artist. AllPosters.com provides unmatched service with a 100% satisfaction guarantee. We ship internationally to over 80 countries. Decorate your... |
 |
"Liposure Control, Level 1 - Lipoprint Lipoprotein Subfractionation Systems, Quantimetrix" by Quantimetrix Liposure Control, Level 1 - Lipoprint Lipoprotein Subfractionation Systems, Quantimetrix : Designed for the electrophoretic separation and quantification of subfractions of LDL or HDL cholesterol from patient serum samples. Systems are composed of precast, ready-to-use polyacrylamide gel tubes; loading gel with lipophilic dye to prestain the li |
| © 2009 BrightSurf.com |